The Centers for Medicare and Medicaid Services (CMS) publishes quality ratings on a scale of one to five stars for thousands of US hospitals. However, the method used to calculate these ratings is problematic, according to Chicago Booth’s Dan Adelman. To address some of its limitations, Adelman developed the Efficient Frontier Hospital Ratings system, an alternate method of generating quality scores. To illustrate how his system compares, he inputted the same data (collected over 2014–18) that the CMS used for its February 2019 release and scored more than 3,700 individual hospitals. A searchable database showing how each of these hospitals fared under the two systems is now available here on the Chicago Booth Review website.
The most influential rating system rests on some faulty calculations, affecting millions of people and billions of dollars.
Hospital Ratings Are Deeply Flawed. Can They Be Fixed?The CMS and other reviewers use mostly the same data, but the results they come up with can be very different. The Johns Hopkins Hospital, for example, was, in 2019, ranked as the No. 3 hospital in the country by US News & World Report and received a top-5-percent designation from Healthgrades. But it received a B in the fall from Leapfrog and only three stars from the CMS.
While the CMS rates US hospitals as a single homogeneous group, Adelman introduced a way to put hospitals into subgroups with similar characteristics, and then recalculate their ratings. These subgroups include:
The example below, highlighting a set of scores for Johns Hopkins, illustrates this type of grouping. As an alternative to rating it against a full, nationwide list of 3,720 hospitals (in which it lands in the 37th percentile), Adelman’s system makes it possible to rate Johns Hopkins among a narrower grouping of 138 peer institutions—all teaching hospitals with at least 400 beds—in which it stands in the 69th percentile. (Search the full Efficient Frontier database.)
Adelman, 2020
Data from India show a decline in the accessibility of regulated medicines, as companies cut back on marketing them.
The Downside of Drug Price Caps: Fewer Sales
Chicago Booth’s Anil K Kashyap and former Chicago Fed president Charles Evans discuss how the Fed is thinking about the US economy.
When Will the Fed Start Cutting Interest Rates?
A system of international payments could benefit Brazil and the whole world.
Paying Up to Save the Amazon May Be Cheaper than the AlternativeYour Privacy
We want to demonstrate our commitment to your privacy. Please review Chicago Booth's privacy notice, which provides information explaining how and why we collect particular information when you visit our website.